Education

Fellowship
Hematology & Medical Oncology, UCLA School of Medicine, 2013
Fellowship
Hematology & Medical Oncology, Washington University School of Medicine, 2012
Residency
Chief Resident, Washington University School of Medicine, 2010
Residency
Internal Medicine, Washington University School of Medicine, 2009
Internship
Internal Medicine, Washington University School of Medicine, 2007
Degree
MD, Duke University School of Medicine, 2006

Medical Board Certifications

Hematology
American Board of Internal Medicine, 2014
Medical Oncology
American Board of Internal Medicine, 2013
Internal Medicine
American Board of Internal Medicine, 2009

Gender

Female

State License

A121192
  • Locations

    UCLA Hematology Oncology Santa Monica

    (primary location)
    Address
    2020 Santa Monica Blvd
    Suite 600
    Santa Monica, California 90404
    Phone
    310-829-5471
  • Education

    Medical Board Certifications

    Hematology
    American Board of Internal Medicine, 2014
    Medical Oncology
    American Board of Internal Medicine, 2013
    Internal Medicine
    American Board of Internal Medicine, 2009

    Education

    Fellowship
    Hematology & Medical Oncology, UCLA School of Medicine, 2013
    Fellowship
    Hematology & Medical Oncology, Washington University School of Medicine, 2012
    Residency
    Chief Resident, Washington University School of Medicine, 2010
    Residency
    Internal Medicine, Washington University School of Medicine, 2009
    Internship
    Internal Medicine, Washington University School of Medicine, 2007
    Degree
    MD, Duke University School of Medicine, 2006
  • Clinical Interests
    • Advanced Malignancies
    • Biliary
    • Brain Tumor
    • Breast Cancer
    • Cancers of the Digestive Tract
    • Chronic Myelogenous Leukemia
    • Colorectal (colon, rectum and anus)
    • Esophageal Cancer
    • Gastric Cancer
    • Gastrointestinal Malignancies
    • General Oncology
    • Geriatric Breast Cancer
    • Gynecologic Oncology
    • Head and Neck Cancers
    • Hepatobiliary Cancers
    • Liver Cancer
    • Lung Cancer & Chest Malignancies
    • Lymphoma
    • Melanoma
    • Mesothelioma
    • Neuro Oncology
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Renal Cancer
    • Testicular Cancer
    • Thoracic Cancer
    • Unknown Primary
  • Research

    Research Interest

    Breast Cancer, General Oncology

    Publications

    1. Rosove MH, Peddi PF, Glaspy JA. BRAF V600E inhibition in anaplastic thyroid cancer. N Engl J Med. 2013 Feb 14;368(7):684-5.
    2. Peddi PF, Peddi S, Santos ES, Morgensztern D. Central nervous system toxicities of chemotherapeutic agents. Expert Rev Anticancer Ther. 2014 Jul;14(7):857-63.
    3. Peddi PF, Hurvitz SA. PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer. J Neurooncol. 2014 Mar;117(1):7-13.
    4. Kasum M, Beketic-Oreškovic L, Peddi PF, Oreškovic S, Johnson RH. Fertility after breast cancer treatment. Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:13-8.
    5. Peddi PF , Cho M, Wang J, Gao F, Wang-Gillam A. Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma. J Gastrointest Oncol. 2013 Dec;4(4):370-3.
    6. Wainberg ZA, Messersmith WA, Peddi PF , et al. A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2013 Dec;12(4):248-54.
    7. Peddi PF , Shatsky RA, Hurvitz SA. Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer. Cancer Treat Rev. 2014 Mar;40(2):320-6.
    8. Cho M, Peddi PF, Ding K, et al. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma. J Transl Med. 2013 Sep 8;11:206.
    9. Peddi PF, Hurvitz SA. Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer. Future Oncol. 2013 Mar;9(3):319-26.
    10. Peddi PF, Wang-Gillam A. Successful resection after neoadjuvant therapy in pancreatic adenocarcinoma. J Natl Compr Canc Netw. 2012 Nov 1;10(11):1330-4.
    11. Peddi PF, Lubner S, McWilliams R, et al. Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma. JOP. 2012 Sep 10;13(5):497-501.
    12. Peddi PF, Ellis MJ, Ma C. Molecular basis of triple negative breast cancer and implications for therapy. Int J Breast Cancer. 2012;2012:217185.
  • News & Awards

    Awards

    • American Society of Clinical Oncology Young Investigator Award
    • Chief Editor of Washington Manual of Medical Therapeutics, 33rd Edition
    • Mentors in Medicine Research Award, Washington University School of Medicine
    • Howard–Hughes Medical Institute/NIH Scholar, Duke University School of Medicine
    • Phi Beta Kappa
    • Excellence in Research Award, Department of Biological Sciences, Vanderbilt University